Mortality was found to be lower 5% vs. 16% p = 0.02 in patients managed with TIVA, but no relationship was found between TIVA and better neurological outcomes.
Se demostró, una menor mortalidad 5% versus 16% P = 0,02 en los pacientes manejados con TIVA, sin encontrar relación con TIVA y un mejor desenlace neurológico.